Mergers & Acquisitions Mergers & Acquisitions

Elanco-Bayer deal poised for clearance in Brazil

By Ana Paula Candil
  • 11 May 2020 09:52
  • 11 May 2020 09:52
Elanco Animal Health’s planned buyout of Bayer AG's animal health business is poised to receive unconditional antitrust clearance in Brazil, MLex has learned.

The case has been with the investigatory unit of the Administrative Council for Economic Defense, or CADE, for 108 days. 

Full-form deals have taken an average of 32 days to be

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News